Adaptive Biotechnologies (ADPT) Other Non-Current Liabilities (2019 - 2026)
Adaptive Biotechnologies (ADPT) posted Other Non-Current Liabilities of $20000.0 for Q1 2026, little changed sequentially from $20000.0 in Q4 2025, and little changed YoY from $20000.0 in Q1 2025.
Adaptive Biotechnologies (ADPT) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 7 years of Other Non-Current Liabilities data on file, last reported at $20000.0 in Q1 2026.
- Quarterly Other Non-Current Liabilities changed 0.0% year-over-year to $20000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $20000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities steadied at $20000.0 in Q1 2026 per ADPT's latest filing, from $20000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $128.2 million in Q2 2023, with the low at $20000.0 in Q2 2024.
- Average Other Non-Current Liabilities over 5 years is $42.1 million, with a median of $20000.0 recorded in 2024.
- Year-over-year, Other Non-Current Liabilities plunged 99.98% in 2024 and changed 0.0% in 2025.
- Adaptive Biotechnologies' Other Non-Current Liabilities stood at $125.4 million in 2022, then increased by 2.24% to $128.2 million in 2023, then sank by 99.98% to $20000.0 in 2024, then changed by 0.0% to $20000.0 in 2025, then changed by 0.0% to $20000.0 in 2026.
- Business Quant data shows ADPT's Other Non-Current Liabilities at $20000.0 in Q1 2026, $20000.0 in Q4 2025, and $20000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Jun 30, 2023 | 128.17 Mn |
| Mar 31, 2023 | 127.01 Mn |
| Dec 31, 2022 | 125.36 Mn |
| Sep 30, 2022 | 124.56 Mn |
| Sep 30, 2020 | 2.38 Mn |
| Jun 30, 2020 | 1.50 Mn |
| Dec 31, 2019 | 93,000.00 |
| Sep 30, 2019 | 44,000.00 |